Skip to main content

How is Trogarzo used in the treatment of HIV?

Medically reviewed by Drugs.com. Last updated on Sep 30, 2024.

Official Answer by Drugs.com

Trogarzo (ibalizumab-uiyk) is used to treat the small percentage of patients who have multidrug-resistant human immunodeficiency virus type 1 HIV (MDR HIV-1 Infection) and who have failed other HIV therapies.

Trogarzo is a first-in-class CD4-directed post-attachment HIV-1 inhibitor that works by binding to CD4+ receptors on host cells and blocking the HIV virus from infecting the cells. It is the first monoclonal antibody approved for the treatment of MDR HIV-1 infection, and is used in combination with other antiretroviral drugs.

Trogarzo is administered intravenously (IV) once every 14 days by a trained medical professional.

Read next

Can Descovy be used for PrEP in HIV?

Yes. The FDA approved Descovy (emtricitabine and tenofovir alafenamide) for pre-exposure prophylaxis (PrEP) in October 2019 to help reduce the risk of HIV-1 infection. Continue reading

Modafinil (Provigil) vs Adderall: What's the difference?

Modafinil and Adderall are both classified as CNS stimulants but have different chemical structures, which means there are differences in their addiction potential and risk of side effects. Modafinil and Adderall both have stimulant-type effects, but modafinil is a much milder stimulant than Adderall.

Continue reading

Which medicines should not be taken with Biktarvy?

Biktarvy should not be taken with dofetilide (Tikosyn), a drug used for heart rhythm disorders or rifampin (Rifadin), a medicine for tuberculosis (TB). These drugs are contraindicated with the use of Biktarvy, meaning you should never use them with Biktarvy. Other drug interactions include St. John's Wort, some anticonvulsants and some OTC supplements.

Continue reading

See also:

Related medical questions

Drug information

Related support groups